Dexcom G7 Launches in the United Kingdom, Ireland, Germany, Austria and Hong Kong – Initiating Global Rollout of World’s Most Powerful Continuous Glucose Monitoring System

People with diabetes in the United Kingdom, Ireland, Germany, Austria and Hong Kong can get started with Dexcom G7 now The new CGM system is also expected to launch in […]

Surfshark Partners with dLocal to Power Its Global Expansion Across Africa, Asia, and Latin America

The partnership will enable the leading VPN provider to offer localized payments to customers in 13 new countries as part of the company’s overall growth strategy 14/12/2021 — MONTEVIDEO, Uruguay […]

Adagio Therapeutics Announces $336 Million Series C Financing to Support Rapid Advancement of Novel ADG20 #Antibody for the Treatment and Prevention of #COVID-19

Additional Capital to Fund Ongoing STAMP Pivotal Trial of ADG20 Designed to Support Emergency Use Authorization Submission Financing Follows First Quarter Appointment of Industry and Banking Veteran Jane Henderson as […]

Dole Europe Features Its Grapes Business and Announces Investments in the Production of Early Grapes in South Africa at the 2014 Fruit Logistica

At the 2014 Fruit Logistica in Berlin on Feb 5 to 7th, Dole Europe will be highlighting its projects and achievements in the grape category and announcing the potential acquisition of a controlling share in an early grape farm in South Africa, its first direct investment in fruit production in the country. Fruit Care Services (Pty) Ltd., one of Dole Europes subsidiaries located in South Africa, has recently signed a Memorandum of Understanding with a view to purchasing Rekopane, a 600-hectare farm located on the banks of the Orange River, 30km from the South African town of Upington.

Otsuka Receives Opinion from CHMP on Delamanid

Otsuka Pharmaceutical Co., Ltd. (Otsuka) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a negative opinion for delamanid for the treatment of pulmonary multidrug-resistant tuberculosis (MDR-TB) in combination with an optimised background regimen (OBR) according to WHO guidelines in patients. The CHMP considered that the duration of treatment (two months) in the Phase IIb randomised controlled trial (Trial 204) was too short to establish the effectiveness of delamanid in treating tuberculosis when added to other anti-tuberculosis medicines.

Rimini Street Doubles New Client Sales in EMEA

Rimini Street, Inc., the leading third-party maintenance and support provider for enterprise software, including SAP AG (NYSE:SAP) software and Oracle Corporations (NASDAQ: ORCL) Siebel, PeopleSoft, JD Edwards, E-Business Suite, Oracle Database and Hyperion software, today announced that in fiscal year 2012 it more than doubled new sales in EMEA, with 117 percent year-over-year growth in new client invoicing; achieved more than $42 million in new EMEA sales bookings, a 175-percent year-over-year increase; and nearly doubled the total number of clients in EMEA. The Company also announced its expansion and additional investment in EMEA to meet continued growing demand for its SAP and Oracle support services.